Search

everythinglearnresearchcommunity

for

Search:↓

Cyclosporin A, a drug, reduces TGF-β2 expression in skin cells, potentially causing excessive hair growth through a process involving the calcineurin/NFAT pathway.

CCCA may be a fibroproliferative disorder, and anti-fibrotic therapies could help.

Ulcerative colitis involves immune activation, chronic inflammation, and metabolic issues, some of which persist even during remission.

Epidermal stem cells don't use gap junctions to communicate.

A new test using NOS2 and CCL27 genes can better diagnose and treat psoriasis and eczema.

Oral contraceptive use may increase the risk of frontal fibrosing alopecia in women with a specific CYP1B1 gene variant.

The OVOL1 gene, controlled by β-catenin, is crucial for creating hair follicles.

Lack of a key enzyme causes severe skin issues and death in mice.

The microneedles effectively treat infected wounds by killing bacteria, reducing inflammation, and promoting healing.

LC-OCT can help diagnose different types of scarring alopecia.

The "exposure–crossover design" helps assess individual changes in risk after events like car crashes.

Prenatal and postnatal environments both affect PCOS development and gut microbiota in mice.

A specific genetic variation affects wool quality in sheep.

Dimethylarsinic acid speeds up skin tumor growth in certain mice.

Placental cell medium boosts blood vessel growth in lab tests.

Topical cyclosporin promotes hair growth.

CD133+ cells help heal diabetic ulcers by promoting blood vessel growth and activating Wnt signaling.

Combining Cyclosporine A with low-dose corticosteroids effectively treats severe alopecia areata.

A specific gene change in APCDD1 increases the risk of hair loss.

WomenCare helps predict PCOD risk in women to encourage early medical consultation.

COCs can improve acne but may cause skin issues like cholasma; high estrogen is advised for hair loss concerns.

Activated protein C helps protect mice from long-term radiation damage.

Low oxygen levels affect the behavior of certain proteins in human skin cells.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

Allergens might contribute to CCCA, so avoiding them could help manage the condition.

CD44 variant changes start alopecia areata, but don't maintain it.

Substance from human umbilical cord blood cells promotes hair growth.

Certain CD8+ T cells attack hair follicles in alopecia areata, suggesting they could be targeted for treatment.